Carl Schwartz CEO Skyline Medical Skype Interview (NASDAQ:SKLN) Presented at the Dawson James Securities 3rd Annual Small Cap Growth Conference

Carl Schwartz CEO Skyline Medical Skype Interview (NASDAQ:SKLN) Skyline Medical Inc. (NASDAQ:SKLN) producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, presented at the Dawson James Securities 3rd Annual Small Cap Growth Conference at the Wyndham Grand Hotel in Jupiter, Florida.  We caught up with CEO Carl Schwartz

Sigma Labs Can Ensure “Perfect Parts”

n an Interview with Stock-Sector, John Rice, CEO of Sigma, Explains How Sigma's Technology is Essential to a Manufacturing Revolution Known as 3D Printing SAN DIEGO, CA / ACCESSWIRE / October 23, 2017 / CEOCFO Magazine, an independent investment publication that highlights important technologies and companies, today reports on an interview that Stock-Sector conducted with John

Voip-Pal: A Potential Financial Winner in the Patent Legal Wars (OTCQB: VPLM)

Voip-Pal:  A Potential Financial Winner in the Patent Legal Wars In an interview with Stock-Sector, ​Malak explains how Voip-Pal’s strong patents are expected to lead to settlements with major tech and telecom companies—bringing big returns to his shareholders NEW YORK, NY – April 10, 2017 - ​ Stock-Sector.com​, ​ an online source

Innovus Pharmaceuticals Sees Accelerated Growth and Profitability in 2017

In an interview with Stock-Sector, Innovus Pharma’s CEO explains how the company has acquired a rich portfolio of consumer care products—and how those products are now fueling rapid growth into 2017 NEW YORK, NY – October 24, 2016 - Stock-Sector.com, an online source of news about promising medical, technology and energy

Jamie Dimon: ‘lift up’ Americans hurt by free trade

Jamie Dimon: Political environment is 'terrible' Free trade has taken a beating this election season, from the left and the right. But Jamie Dimon believes it would be a mistake to run away from trade deals. Instead, the JPMorgan Chase(JPM) CEO argues the U.S. needs to figure out a way to help

Stock-Sector Discusses Pulmatrix’s Unique Inhaled Drugs in Interview with CEO Dr. Robert Clarke

In an interview with Stock­-Sector, ​Dr. Clarke explains how Pulmatrix is targeting major markets with the iSPERSE technology platform that delivers drugs to the lungs more efficiently. NEW YORK, NY – June 2, 2016 ­ ​Stock­-Sector.com​, ​an online source of news about promising medical, technology and energy companies, today released an interview with

Facebook plans for life after Zuckerberg

Mark Zuckerberg to tear down neighboring homes in Palo Alto Facebook is starting to think about a time when Mark Zuckerberg will no longer be its CEO. The company is asking shareholders to vote on a proposal that allows Zuckerberg's majority voting control to be terminated if he steps down or no